Functional variants in the promoter of interleukin-1β are associated with an increased risk of breast cancer: A case-control analysis in a Chinese population

International Journal of Cancer

Volumn 118, Issue 10, 2006, Pages 2554-2558

  Liu, Jiyong ^a   Zhai, Xiangjun ^a   Jin, Guangfu ^a   Hu, Zhibin ^a   Wang, Shui ^b   Wang, Xuechen ^c   Qin, Jianwei ^d   Gao, Jun ^a   Ma, Hongxia ^a   Wang, Xinru ^a   Wei, Qingyi ^e   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^d JIANGSU CANCER HOSPITAL   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Genetic susceptibility; IL 1 ; Molecular epidemiology; Polymorphism

Indexed keywords

CYTOKINE; CYTOSINE; INTERLEUKIN 1BETA; THYMINE;

ADULT; AGED; AGING; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MENARCHE; MENOPAUSE; METASTASIS; MOLECULAR EPIDEMIOLOGY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; TUMOR GROWTH;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-1; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 33646389571     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21652     Document Type: Article

References (26)

1. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-1999. Int J Cancer 2003;106:771-83.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
3. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
4. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
5. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
6. Levine PH, Pogo BG, Klouj A, Coronel S, Woodson K, Melana SM, Mourali N, Holland JF. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer 2004;101:721-6.
7. Koch I, Depenbrock H, Danhauser-Riedl S, Rastetter JW, Hanauske AR. Interleukin 1 modulates growth of human renal carcinoma cells in vitro. Br J Cancer 1995;71:794-800.
8. Raitano AB, Korc M. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of γ-interferon receptors. Cancer Res 1993;53:636-40.
9. Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 1995;92:2840-4.
10. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, Turkel G, Polverini PJ, et al. Expression of interleukin-1β in human breast carcinoma. Cancer 1997;80:421-34.
11. Honma S, Shimodaira K, Shimizu Y, Tsuchiya N, Saito H, Yanaihara T, Okai T. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J 2002;49:371-7.
12. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
13. Erratum in Nature 2001;412:99.
14. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201.
15. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-71.
16. Ito LS, Iwata H, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwase T, Miura S, Okuma K, Inoue M, Hirose K, Tajima K. Significant reduction in breast cancer risk for Japanese women with interleukin 1β-31 CT/TT relative to CC genotype. Jpn J Clin Oncol 2002;32:398-402.
17. Yang J, Hu Z, Xu Y, Shen J, Niu J, Hu X, Guo J, Wei Q, Wang X, Shen H. Interleukin-1β gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 2004;215:191-8.
18. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
19. Kurtzman SH, Anderson KH, Wang Y, Miller LJ, Renna M, Stankus M, Lindquist RR, Barrows G, Kreutzer DL. Cytokines in human breast cancer: IL-1α and IL-1β expression. Oncol Rep 1999;6:65-70.
20. Campa D, Hung RJ, Mates D, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova E, Bencko V, Foretova L, Janout V, Boffetta P, et al. Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:538-9.
21. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. Polymorphisms of the interleukin-1 β gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 2004;109:353-6.
22. Wang Y, Kalo N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M. Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003;37:65-71.
23. Matsuo K, Hamajimab N, Suzuki R, Nakamura S, Seto M, Morishima Y, Tajima K. No substantial difference in genotype frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Haematologica 2001;86:602-8.
24. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104:617-23.
25. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, Dong SH, Kim HJ, Kim BH, Lee JI, Chang R. Interleukin-1β (IL-1β) polymorphisms and gastric mucosal levels of IL-1β cytokine in Korean patients with gastric cancer. Int J Cancer 2005;114:465-71.
26. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201.